Antivirus

Achillion's 'Very Promising' Drug for Hepatitis C

Viral hepatitis is the leading cause of liver cancer and the most common reason for a liver transplant. Currently, few therapeutic options exist, but Achillion is hotly pursuing a "protease inhibitor" that can block the hepatitis C virus's action.